Role of Biomarkers and it’s trend to predict the outcome of COVID patients, retrospective review
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 130
- 试验地点
- 1
- 主要终点
- To study the trend of biomarkers and it’s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.
研究概览
简要总结
Use ofvarious biomarkers is being investigated and proposed biomarkers are C reactiveprotein CRP, LDH, D Dimer, Ferritin, Troponin I , Procalcitonin and IL 6. Useof these various biomarkers has been studied widely and can be suggested to beused for prognostication. The simple biomarker such as Neutrophil/ Lymphocyteratio also can help in predicting outcome.
The aim of our study is to evaluatethe trend of various biomarkers done for these patients and can it be used topredict the outcome of COVID 19 patients.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients with COVID 19 pneumonia admitted in ICU.
排除标准
- 未提供
结局指标
主要结局
To study the trend of biomarkers and it’s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.
时间窗: ICU mortality or at the end of 4 weeks | Hospital mortality or at the end of 90 days
次要结局
- 1.To study the number of ventilator free days(2. To study the difference in ICU length of stay)
